Back
Keros Therapeutics Vs. Simulations Plus Industry Stock Comparison
Buy
62
KROS
Keros Therapeutics
Last Price:
60.94
Seasonality Move:
54.08%
Sell
29
SLP
Simulations Plus
Last Price:
30.22
Seasonality Move:
5.81%
Buy
62
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $59.90. The Score for KROS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy, Sell or Hold?
- The current Simulations Plus [SLP] share price is $30.24. The Score for SLP is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- SLP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $59.90
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight selling pressure.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $30.24
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing slight selling pressure.
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.56 | Buy |
| Relative Strength Index (14 RSI): | 66.54 | Buy |
| Chaikin Money Flow: | -96535 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.06 - 58.76) | Buy |
| Bollinger Bands (100): | (44.97 - 54.01) | Buy |
SLP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.31 | Sell |
| Relative Strength Index (14 RSI): | 30.98 | Sell |
| Chaikin Money Flow: | -3761 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.89 - 34.25) | Sell |
| Bollinger Bands (100): | (34.11 - 46.87) | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.06 | Buy |
| 20-day SMA: | 56.39 | Buy |
| 50-day SMA: | 51.03 | Buy |
| 200-day SMA: | 53.41 | Buy |
| 8-day EMA: | 58.51 | Buy |
| 20-day EMA: | 56.04 | Buy |
| 50-day EMA: | 52.75 | Buy |
| 200-day EMA: | 50.31 | Buy |
SLP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.1 | Sell |
| 20-day SMA: | 31.9 | Sell |
| 50-day SMA: | 35.08 | Sell |
| 200-day SMA: | 41.64 | Sell |
| 8-day EMA: | 31.12 | Sell |
| 20-day EMA: | 32.14 | Sell |
| 50-day EMA: | 34.98 | Sell |
| 200-day EMA: | 40.27 | Sell |
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.44 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.08 per share.
Keros Therapeutics Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Simulations Plus Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||